Melbana Energy Ltd

Biopharma Job Market Recovery Expected by Late 2026 Despite Current Downturn

- Industry experts predict the biopharma job market will begin recovering in late 2026, despite over 57% of professionals expecting the turnaround to occur no earlier than 2027. - Biopharma hiring activity remains down 32% year-over-year in October 2025, with over 41,000 employees laid off or projected to be cut through October this year. - Early recovery signals include increased M&A activity with major deals totaling billions, October funding reaching $8.5 billion (up 87% year-over-year), and emerging opportunities in cell therapy, immunology, and radiopharma sectors. - Structural changes including AI-enabled regulatory modernization, biomanufacturing reshoring, and health-economic discipline are expected to accelerate the market turnaround.